FDA approves Pfizer COVID-19 booster for 65 and older, others at high risk

Name: FDA approves Pfizer COVID-19 booster for 65 and older, others at high risk
Uploaded: 2021-09-23T11:42:56Z
Duration: 4 min 41 s
Description: After striking down widespread COVID-19 booster shots, the FDA OK'd Pfizer's third dose for people 65+ and those with specific health risks. Dr. Mike joins Good Day Philadelphia to discuss the decision.

After striking down widespread COVID-19 booster shots, the FDA OK'd Pfizer's third dose for people 65+ and those with specific health risks. Dr. Mike joins Good Day Philadelphia to discuss the decision.

Posted September 23, 2021 7:42am EDT